
Dr. Betty Cohn discusses the complexities, ethical considerations, and current state of polygenic embryo screening and risk scores, highlighting the scientific, ethical, and societal challenges involved. Key words: polygenic embryo screening, genetic testing, reproductive ethics, risk scores, embryo selection, genetic diversity, clinical validity, reproductive autonomy, bioethics Key Topics: What polygenic embryo screening is and how it differs from single-gene testing The probabilistic nature of polygenic risk scores and their limitations Ethical implications of embryo selection based on risk scores Disparities and biases in polygenic risk scoring across ancestry groups The influence of commercial companies and lack of regulation in direct-to-consumer genetic testing The impact of societal values in embryo selection Guest bio: Betty Cohn is a postdoctoral fellow working with Dr. Anna Wexler at the University of Pennsylvania. She holds a PhD in Public Health Genetics from the University of Washington, a Master of Bioethics from the Johns Hopkins Berman Institute of Bioethics, and a B.A. from Binghamton University. Her research examines the ethical, legal, and social implications of emerging biotechnologies, including direct-to-consumer genetic testing, brain organoids, and polygenic risk scores. Her doctoral dissertation used qualitative methods to explore how individuals who discover a misattributed parentage experience through genetic testing navigate these findings, with a focus on online communities as sources of social support. LinkedIn: https://www.linkedin.com/in/bettycohn/ Twitter/X: @bettyccohn Resources related to today’s topic: “Ethical and social implications of implementing polygenic embryo screening into clinical care: A scoping review” by Betty Cohn, Dorit Barlevy, Gabriel Lazaro-Munoz “Polygenic risk scores in the clinic: Health-system leaders and primary care providers weigh in” by Susan Brown Trinidad, Stephanie M Fullerton, Betty Cohn, David R Crosslin, Gail P Jarvik “Human Demographic History Impacts Genetic Risk Prediction across Diverse Populations” by Martin et al. Give your feedback and help shape All Access DNA! Take our listener survey here: https://forms.gle/x82MKLRftpKH987s7 Sign up for our newsletter here: https://www.allaccessdna.com/newsletter Please subscribe to this podcast on Apple Podcasts, Spotify, YouTube or wherever you get your podcasts to stay updated on new episodes of All Access DNA. Listen to past episodes on your favorite podcast play by searching “All Access DNA” or by streaming from our website at allaccessdna.podbean.com Any inquiries on the podcast can be sent to AllAccessDNA@gmail.com Note that this podcast is for entertainment and education and is not intended to be a substitute for professional medical advice. Please consult your physician with any questions you may have regarding your health. The All Access DNA team includes: host, producer and editor Kate Wilson. The logo is designed by Designs by NKJ. Our Social Media Lead is Aryanah Estinvil.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

#63-How can you cure ALS & FTD in a race against time?

#62- Is the healthcare experience keeping genomic medicine out of reach?

How does Jack's Basket celebrate people with Down syndrome?

#60: How do I know if I have a hereditary bleeding disorder?
Free AI-powered recaps of All Access DNA and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.